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The main causes of non-communicable diseases (NCDs), health 
inequalities and health inequity include consumption of unhealthy 
commodities such as tobacco, alcohol and/or foods high in fat, salt 
and/or sugar. These exposures are preventable, but the commodities 
involved are highly profitable. The economic interests of ‘Unhealthy 
Commodity Producers’ (UCPs) often conflict with health goals but their 
role in determining health has received insufficient attention. In order 
to address this gap, a new research consortium has been established. 
This open letter introduces the SPECTRUM (Shaping Public hEalth poli
Cies To Reduce ineqUalities and harM) Consortium: a multi-
disciplinary group comprising researchers from 10 United Kingdom 
(UK) universities and overseas, and partner organisations including 
three national public health agencies in Great Britain (GB), five multi-
agency alliances and two companies providing data and analytic 
support. Through eight integrated work packages, the Consortium 
seeks to provide an understanding of the nature of the complex 
systems underlying the consumption of unhealthy commodities, the 
role of UCPs in shaping these systems and influencing health and 
policy, the role of systems-level interventions, and the effectiveness of 
existing and emerging policies. Co-production is central to the 
Consortium’s approach to advance research and achieve meaningful 
impact and we will involve the public in the design and delivery of our 
research. We will also establish and sustain mutually beneficial 
relationships with policy makers, alongside our partners, to increase 
the visibility, credibility and impact of our evidence. The Consortium’s 
ultimate aim is to achieve meaningful health benefits for the UK 
population by reducing harm and inequalities from the consumption 
of unhealthy commodities over the next five years and beyond.
Keywords 
Public health, Policy, Inequalities, Non-communicable disease, 
Prevention, Tobacco, Alcohol, Unhealthy commodities, Commercial 
determinants
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Background
The main causes of non-communicable diseases (NCDs) include 
consumption of unhealthy commodities such as tobacco, alco-
hol or foods high in fat, salt and/or sugar. These exposures 
are preventable, but the commodities involved are highly 
profitable. Their consumption and health and social impacts 
are also inequitable and driven by complex systems of produc-
tion, distribution and promotion dominated by transnational 
companies - Unhealthy Commodity Producers (UCPs). UCPs’ 
economic interests often conflict with health goals and their 
role in determining health has received insufficient attention.
SPECTRUM (Shaping Public hEalth poliCies To Reduce 
ineqUalities and harM) is a multi-university, multi-agency research 
consortium that aims to shape public health policies and prac-
tices that focus on the prevention of NCDs and the reduction 
of health inequalities caused by the consumption of unhealthy 
commodities1. It is funded by the UK Prevention Research 
Partnership (UKPRP)2, and builds on the strong foundation of 
the UK Centre for Tobacco and Alcohol Studies (UKCTAS): a 
strategic partnership funded by the UK Clinical Research Col-
laboration that included 14 university academic groups work-
ing collaboratively on research, teaching, training and policy 
development to prevent harms to health and wider society 
arising from tobacco and alcohol use between 2013 and 2018.
SPECTRUM brings together researchers from 10 UK Univer-
sities with support from academics overseas. Our work will 
be developed with a range of partner organisations includ-
ing health bodies, charities, and companies who provide data 
and whose staff have skills that can enhance our research. We 
will involve the public through regular meetings with groups 
made up of members of the public (user panels), specific meet-
ings such as citizens’ juries, and by interviewing people from 
communities across the country. We will work with our part-
ners, politicians, civil servants, and health and social care pro-
fessionals amongst others to jointly design and deliver research 
so that it meets public and professional needs. We anticipate 
SPECTRUM will accelerate and improve the use of accel-
erate the use of evidence to inform new and existing health 
policy and practices in the UK, and to develop research that 
will also support progress in other countries.
Priority areas
SPECTRUM will generate new evidence to inform the pre-
vention of NCDs caused by unhealthy commodities focusing 
on tobacco and alcohol and now extending work to unhealthy 
food and drinks. 
Tobacco. Smoking is the leading cause of preventable illness 
and premature mortality in the UK and around the world3. It 
is a major risk factor for many diseases including lung can-
cer, chronic obstructive pulmonary disease (COPD), stroke and 
heart disease4. Smoking is responsible for an estimated 95,000 
deaths per year in the UK and costs society approximately 
£12.5 billion per year in England5,6.
There has been a significant decline in the proportion of 
smokers in the UK in recent years: from 20.2% in 2011 to 
14.1% in 20196. However, this still equivalent to an estimated 
6.9 million smokers in the UK in 20196. There are large 
inequalities in the proportion of current smokers by deprivation, 
ethnic group, sexuality, occupation, mental health status and 
geographical area of residence4. These inequalities exist 
despite robust evidence of effective tobacco control measures 
that can reduce smoking prevalence at the population level.
Alcohol. Alcohol consumption is a causal factor in more than 
200 physical and mental health conditions and intentional 
and non-intentional injuries7,8. Alcohol misuse is the fifth big-
gest risk factor for preventable illness, premature mortality, 
and disability in England, for example, and the leading risk fac-
tor amongst those aged 15 to 499. In 2018, there were 7,551 
avoidable deaths in the UK that were caused by alcohol10.
Alcohol-related harm disproportionately affects those with 
low individual or neighbourhood socioeconomic status/posi-
tion (SES)11–13. Those in low SES classifications are at almost 
twice the risk of alcohol-related mortality than individuals in 
higher SES classifications11.
It is estimated that the total cost of alcohol-related harm 
was 2.5% of gross domestic product (GDP) of high-income 
countries in 2007: equivalent to £47 billion in the UK in 201614,15.
Unhealthy food and drinks. Almost two thirds of adults in 
the UK are overweight or obese, and in 2019 more than one 
in three children in England left primary school overweight or 
obese16,17. Excess weight is a leading cause of diabetes, car-
diovascular disease, at least 12 different types of cancer, and 
mental ill-health18,19. Obesity-related illnesses cost the NHS 
around £6 billion per year20.
Obesity prevalence is greater with higher levels of depriva-
tion, and children living in the most deprived parts of the 
country are more than twice as likely to be obese as children 
living in the least deprived areas17.
Unhealthy diets that include food and drinks that are high in 
fat, sugar and/or salt (HFSS) are a major contributor to over-
weight and obesity. In July 2020, the Government published 
a new obesity strategy that, when implemented, will aim to 
change elements of the food environment21. The strategy pro-
poses a future ban on advertising HFSS products online and on 
TV before 9pm, a restriction on promotional deals (such as 
‘buy one get one free’) on HFSS products, and the require-
ment for food businesses with over 250 employees to provide 
calorie labels on food items21.
Aims and objectives
Priority objectives
SPECTRUM’s five priority objectives are to:
1.    develop and evaluate interventions to prevent harm 
from tobacco and alcohol use, and extend this work to 
HFSS food and drinks;
2.    provide timely evidence to inform policy and practice;
3.    understand and address industry strategies;
Page 4 of 9
Wellcome Open Research 2021, 6:6 Last updated: 14 JAN 2021
4.    identify how systems can meet the challenge of these 
preventable risk factors;
5.    understand the economic costs and benefits of 
system change and their implications for inequalities.
Theory of change
As illustrated in our Theory of Change (Figure 1), we expect 
SPECTRUM to achieve meaningful benefits for the UK popu-
lation, particularly by contributing to reduced consumption, 
harm and inequalities arising from unhealthy commodities 
in the medium to long term (5 to 10 years). This will be 
achieved by ensuring that we meet our impact goals which are 
described in more detail below (see Impact and anticipated 
outputs). The three main goals are:
1.    co-produce evidence to underpin the development, 
enactment, evaluation and maintenance of large-scale 
generalizable and cost-effective interventions to reduce 
consumption, harm and inequalities arising from 
unhealthy commodities;
2.    establish, enhance and sustain mutually beneficial rela-
tionships with policy and other partners to increase 
the visibility, credibility and impact of SPECTRUM 
evidence, and to make the case for future investment in 
NCD prevention and commercial determinants of health 
research;
3.    embed sustainable and meaningful strategies for pub-
lic involvement to ensure our research, outputs and 
activities are accessible and grounded in lived experience.
In the short to medium term, SPECTRUM research will sup-
port devolved and national governments to develop, enact 
and sustain evidence-informed, innovative policy and prac-
tice changes and strategies to reduce NCD harm and inequali-
ties. For example, both the UK and Scottish Governments are 
considering new or revised alcohol, and tobacco strategies, 
including greater regulation of price, availability and promo-
tions. Through SPECTRUM, researchers, advocacy organisa-
tions, non-governmental organisations (NGOs) and the public will 
co-create evidence to highlight and counter the influence of 
UCPs and develop cross-sectoral governance approaches. 
Working in coalition with advocacy and civil society partners, 
SPECTRUM will draw and build on existing relationships 
with policymakers to shape research to policy needs. Emerging 
Figure 1. Theory of Change.
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evidence will be fed into a two-way dialogue leading to prac-
tice and policy change in local authorities, the NHS, devolved 
administrations and national government.
SPECTRUM work packages (WPs)
SPECTRUM has eight integrated work packages, which together 
form a cohesive programme of work to inform our theory of 
change. The interactions between these will provide a layered 
understanding of the nature of the complex systems underlying 
the consumption of unhealthy commodities, the role of UCPs 
in shaping these and influencing health and policy, the role of 
systems-level interventions, and the effectiveness of existing 
and emerging policies.
WP1: Using systems approaches to understand determinants and 
address harms
WP1 aims to develop systems-based approaches and perspec-
tives that can be applied to a range of UCPs and different 
types of research including new primary studies and evidence 
syntheses and then apply these in new case studies, chosen 
to allow the analysis of the system-level drivers of specific 
public health harms related to unhealthy commodities. WP1 
will assess the potential for transferring a new conceptual 
model and general methodological approach to other unhealthy 
commodities or services (such as HFSS foods), to public-private 
partnerships, and to particular settings and/or populations (e.g. 
schools, and children and young people) within the whole 
system. WP1 aims to use a causal loop diagram approach to 
identify parts of the system within which there is potential for 
intervention, and to identify how under-researched sub-systems 
may facilitate and/or reduce the effectiveness of intervention.
WP2: Understanding and addressing unhealthy commodity 
industry influence
WP2 aims to understand how UCPs influence health and public 
policy, through targeted case studies of corporate political 
activity around emerging NCD policies, and develop a con-
ceptual model for understanding the commercial determinants 
of health, with an emphasis on UCPs. WP2 will compile 
evidence of best practice through reviews of the academic and 
grey literature and key informant interviews (with creators 
and users of the research) aiming to identify the specific types 
of research and knowledge translation most likely to enable 
policy change. WP2 will develop a model of the commercial 
determinants of health, drawing on evidence of the diverse 
ways UCPs’ practices impact on health, the emerging body of 
literature profiling the commercial determinants of health, and 
the ongoing review of strengths and weaknesses of existing 
models of determinants of health.
WP3: Developing and integrating new data sources to inform 
action
The Smoking and Alcohol Toolkit Study (STS/ATS) (www.
smokinginengland.info and www.alcoholinengland.info) is a 
national monthly survey established in 2006 that aims to provide 
insight into population-wide influences on smoking and alco-
hol in England. Each month a new sample of around 1700 
adults (age 16+ years) complete a computer-assisted house-
hold survey with a trained Ipsos MORI interviewer with around 
270,000 responses recorded to date. Respondents are selected 
by a hybrid method between random location and sim-
ple quota sampling and the sample is nationally representa-
tive in its socio-demographic composition. WP3 will expand 
detailed monthly surveillance of preventable risk factors in the 
STS/ATS across GB and constituent nations using new par-
ticipatory methods to refine data collection in response to 
evolving policymaker needs and public interest. WP3 will also 
work with WPs 4, 6 and 7 to develop and apply new methods 
from applied statistics and economics for integrating data and 
forecasting new trends and develop a microsimulation model 
of smoking and quitting in GB to identify emergent effects 
from divergent policy scenarios. 
WP4: Economic and health impact evidence synthesis to inform 
policy and practice decisions
WP4 will develop new evidence, modelling and analysis on the 
impacts of alcohol and tobacco, their associated diseases, and 
prevention policies on the wider economy, focussing on wider 
complex system effects of unhealthy commodities and preven-
tion policies in the UK. WP4 will also develop and extend the 
Sheffield Tobacco and Alcohol Policy Model (STAPM) for 
England to analyse the economic and health impacts of changes 
in use of alcohol and/or tobacco on a wide range of outcomes 
and produce new versions for both Wales and Scotland, thus 
enabling between-country comparisons. WP4 will integrate 
this modelling and economic analysis with evidence from 
the other WPs to undertake policy evaluation (retrospective), 
appraisal (prospective), and scenario analyses (modelling) 
from an economic perspective, with a focus on the impact of 
UCP activities intended to defeat or delay regulation or policy 
implementation.
WP5: Shaping the local environment to change behaviour and 
prevent harm
WP5 aims to examine the intended and unintended impacts of 
(and interventions in) the local commercial environment on 
the consumption of unhealthy commodities by compiling a 
comprehensive interactive mapping platform to integrate data 
on alcohol, tobacco and food outlet and advertising locations 
with information tracking people’s mobility. To do this, WP5 
will develop novel geographical analyses to model the impacts 
and unintended consequences of policy approaches designed to 
change local environments. WP5 will merge data on avail-
ability, price, marketing and norms to examine how these factors 
interact, building on the existing publicly accessible platform 
for mapping tobacco and alcohol environments in Scotland to 
develop a comparable resource for tobacco, alcohol and food 
retailing across GB.
WP6: Evaluating the effectiveness of policies and natural experi-
ments
WP6 will assess the effects of tobacco and alcohol policies 
(such as standardised packaging for tobacco and MUP for alco-
hol in Scotland) on product diversity, price and consumption 
using a standardised framework, and extend the framework 
to food policy. WP6 will identify strategies used to circumvent 
advertising restrictions and potential inadequacies of existing 
regulatory approaches related to unhealthy commodity imagery 
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in the media, and evaluate implementation of tobacco and 
alcohol treatment in the healthcare system.
WP7: Disrupting the relationship between mental health, stigma 
and unhealthy commodities
WP7 aims to understand the relation between unhealthy 
commodities, mental ill-health, and stigma, and to explore how 
these relationships can be disrupted over time by investigat-
ing the relationship between unhealthy commodities and 
mental ill-health, and the impact of UCPs, governmental and 
non-governmental initiatives on these relationships. Through 
the establishment of a new panel of people with mental health 
problems, WP7 will explore how people with mental ill-health 
who smoke and/or use alcohol perceive government mass 
media campaigns and UCP marketing campaigns and how these 
affect their behaviour and influence norms/stigmatization and 
evaluate new co-designed health communication strategies. 
WP7 will also examine how UCPs position their products in 
relation to social norms and mental health.
WP8: Towards governance for health equity
WP8 aims to identify how health governance and regulatory 
mechanisms can be used to develop coherent approaches to 
tackling the health and social impacts of unhealthy commod-
ity industries. By understanding opportunities for and barriers 
to integrated approaches to NCD prevention, identifying 
potential mechanisms to promote co-ordination across policy 
areas that are typically siloed, WP8 will assess the adequacy 
of current practices via multiple methods including system-
atically reviewing researchers’ perceptions of conflict of interest 
and of the effectiveness of existing governance tools. WP8 
will use citizens’ juries to build on work undertaken in WP5 to 
explore neighbourhood social norms and maximize the legiti-
macy and acceptability of policy innovation and of legal and 
other regulatory frameworks for NCD prevention.
Plans for co-production and knowledge exchange
SPECTRUM members and partners
The SPECTRUM Consortium includes 11 universities: Bath, 
Bristol, Cardiff, Edinburgh, Nottingham, Sheffield, Stirling, 
King’s College London, London School of Hygiene and Tropi-
cal Medicine, University College London and the Austral-
ian National University. It also includes the main public health 
agencies (Public Health England, Public Health Scotland, and 
Public Health Wales) in Great Britain. Additionally, part-
ners include The Retail Data Partnership, Sandtable, and the 
Alcohol Health Alliance, Smokefree Action Coalition, Obes-
ity Health Alliance, NCD Alliance and the Poverty Alliance. 
Co-production is central to our approach to advancing research 
and achieving impact. Impact plans have been developed based 
on policy and advocacy needs identified through stakeholder 
engagement prior to and throughout the consortium development 
grant phase.
Knowledge exchange. Our approach to knowledge exchange 
involves planned activities for the Consortium and each WP but 
will also be dynamic and flexible, building on existing strong 
relationships with research users. This flexibility is essential 
to feed evidence and co-produced intervention options aris-
ing from our research into policy debates at national and 
local level in a timely manner.
SPECTRUM will host events for stakeholders, bringing together 
policy makers, NGOs, public health and health professional 
bodies, lay representatives, co-applicants and partners, to 
share research findings and seek input on next steps. WPs will 
attend stakeholder and policy conferences, sharing their research 
through presentations and workshops to expand coalitions and 
engage new partners. SPECTRUM will deliver continuing 
professional development (CPD) workshops for academ-
ics, policy, and advocacy and practice colleagues on alcohol 
policy and tobacco/nicotine. These will be delivered by academ-
ics and partners and will facilitate knowledge exchange, capac-
ity building, networking, policy influence, coalition building 
and bid development.
Knowledge brokers. Three knowledge broker positions have 
been created as secondment posts from PHE, PHW and 
NHS Health Scotland. The main purpose of these roles is to 
facilitate co-production between the SPECTRUM WPs and 
public health agencies, build relationships with policymakers 
to support SPECTRUM to deliver high-impact, policy-relevant 
outputs, and to ensure researchers are front and central in live 
policy discussions. 
Public involvement. We will work closely with the public 
through involvement panels, citizens’ juries and qualitative 
research. Three public involvement panels have been set up and 
will meet regularly to co-produce research, inform debate and 
shape the research agenda:
1.    Alcohol (and Food Policy) Discussion Group.
2.    Tobacco and Nicotine Discussion Group (TANG).
3.    Mental Health Service Users’ Discussion Group.
Impact and anticipated outputs
An effective communications strategy will be essential to 
achieving our three impact goals referred to previously
Our communications activities will be embedded within, and 
complementary to, collaborative working and ongoing two-way 
dialogue with research users, rather than being limited to 
publishing findings. Each work package will develop an impact 
plan which will include a timeline for communication activities 
and outputs.
The primary audience for SPECTRUM research will be poli-
cymakers at all tiers of government. However, impact will 
also be enhanced through communication with other research 
users: civil society, health organisations and practitioners, 
advocacy partners, research funders and the media, and diverse 
public audiences. Our communication will be tailored to each 
of these groups. Messages arising from the evidence gener-
ated through SPECTRUM research will be co-produced and 
incorporated into research outputs. Messages will focus on key 
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SPECTRUM findings in relation to policy, practice and 
governance options to address commercial determinants of 
health within complex systems, effectiveness and economic 
analysis of policy and practice interventions and reduction of 
inequalities, and mental ill-health and stigma.
Outputs
In addition to peer-reviewed publications, SPECTRUM will 
deliver a range of outputs. For example, we will develop new 
conceptual models on the commercial determinants of health 
(WP2) and on systems-level impacts of alcohol advertising 
and regulatory responses, and in a separate case study, to bet-
ter understand on conflicts of interest (WP1). New analytic 
frameworks will also be developed, including modelling infra-
structure to evaluate and appraise the impact of alcohol and 
tobacco policies across the wider economy and enable com-
parisons in these impacts to be drawn across England, Wales 
and Scotland (WP4). The conceptual models we develop will be 
presented as infographics to share with policy makers and NGOs 
to enhance understanding of the issues and applications of these 
models (i.e., WP2). We will also develop consensus principles/
guidance for management of conflicts of interest in relation-
ships between local/national policy or research stakeholders and 
commercial actors in the alcohol, tobacco/nicotine and food 
sectors (WP8), and new co-designed campaign messaging (to 
inform the work of Cancer Research UK (CRUK), PHE etc.) to 
avoid stigmatising vulnerable groups (WP7). We will also pre-
pare infographics or short animations for the general public to 
raise critical consciousness of corporate influence on health and 
society (WP2) and illustrated reports of child and youth expo-
sure to alcohol, tobacco and HFSS food promotion/normalisa-
tion through popular media (WP6). Open access websites (WP3) 
will report monthly survey results from the tobacco and alcohol 
toolkits for England, Scotland and Wales. A publicly accessible 
mapping platform (WP5) will allow a range of research users 
to access bespoke information on tobacco, alcohol and food 
environments (outlet density, pricing, harms) by postcode or 
other geographic levels (e.g. licensing board, local authority) 
across GB. These outputs will be synthesised in a range of policy 
options briefing papers and press releases that highlight the 
availability of infographics and illustrated reports will synthesise 
these outputs and present them in a format tailored for specific 
audiences. Finally, SPECTRUM will partner with the Obesity 
Health Alliance to produce an independent obesity strategy for the 
UK that includes ambitious objectives to be achieved in both 
the short and longer term. This will include policy recommen-
dations and priorities for future research, which will inform 
our work and that of other researchers and research users.
Covid-19 pandemic
The COVID-19 pandemic has caused a tragic loss of life and 
unprecedented change across the globe. The pandemic has 
resulted in social and emotional upheaval not seen since the 
Second World War. Markets and corporations have been as 
affected as any other sector, arguably even more so. The pan-
demic has changed business models and practices across mul-
tiple sectors. In some sectors, high volume, low cost business 
models are struggling to survive, for example in the service sec-
tor. Yet in other areas, such as the retail sector high volume, low 
cost businesses are booming. The pandemic illustrates that the 
commercial determinants of health are more important than ever 
for health. SPECTRUM will shine a light on these determi-
nants of health and work with policy and practice partners 
during and following the COVID-19 crisis.
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